Table 2.
Cisplatin exposure table.
| Renal status/timing | n | % | Cumulative cisplatin exposure |
|---|---|---|---|
| No AKD; completed 3 cycles | 1,458 | 100% of non-AKD | 225 mg/m2 |
| AKI/AKD after cycle 1 | 166 | 28.9% of AKD | 75 mg/m2 |
| AKI/AKD after cycle 2 | 278 | 48.3% of AKD | 150 mg/m2 |
| AKI/AKD after cycle 3 | 131 | 22.8% of AKD | 225 mg/m2 |